JOURNAL BACTERIOLOGY, Apr. 1997, p. 2267–2273                                                                                               Vol. 179,  7
0021-9193/97/$04.0010
Copyright q 1997, American Society Microbiology



   aarC, Essential Gene Involved Density-Dependent Regulation
           29-N-Acetyltransferase Providencia stuartii
                       PHILIP N. 1,2* KIMBERLY  SOLINSKY,2 MICHAEL R. PARADISE,2
                                                                     1
                                              MILICA M. PAROJCIC

          Research Service, Veterans Affairs Medical Center,1 Departments Medicine Molecular Biology                    Microbiology, Case Western Reserve University School Medicine,2 Cleveland, Ohio 44106
                                             Received 30 August 1996/Accepted 3 December 1996

             2*-N-acetyltransferase [AAC(2*)-Ia] Providencia stuartii dual function involved           acetylation peptidoglycan certain aminoglycosides. search negative regulators aac(2*)-Ia
          gene resulted identification aarC. missense allele (aarC1) resulted 8.9-fold increase           b-galactosidase accumulation aac(2*)-lacZ transcriptional fusion. Northern blot analysis demon-
          strated increase aac(2*)-Ia mRNA accumulation specific cells high density. addition,           aarC1 allele resulted substantial increase expression aarP, transcriptional activator           aac(2*)-Ia gene. wild-type aarC gene isolated complementation encodes predicted protein           365 amino acids molecular mass 39,815 Da. predicted AarC protein exhibited 88  amino acid
          homology previously identified GcpE protein Escherichia coli 86  homology gene product
          Haemophilus influenzae. E. coli gcpE gene able functionally complement aarC1 allele           P. stuartii. aarC1 allele identified T G transversion resulted valine glycine substi-
          tution position 136 AarC protein. aarC gene appears essential cell viability construc-
          tion disrupted copy (aarC::lacZ) possible cells carried episomal copy aarC gcpE.


   Providencia stuartii gram-negative enteric bacterium                 high density;  aarC act pathway sponsible variety human infections, especially                P. stuartii responds density-dependent signal. urinary tract (11, 16, 25). family Enterobacte-
riaceae, P. stuartii members tribe Proteeae                                            MATERIALS METHODS
(Proteus Morganella spp.) contain unique modification                    Bacterial strains, plasmids, growth conditions. P. stuartii PR50 wild- peptidoglycan corresponding O acetylation C-6 hy-                  type strain described previously (20) parent strain droxyl muramic acid (4). modification proposed                    isolation mutants (Table 1). E. coli XL1-Blue (Stratagene) DH5a
control activity autolysins, serving sub-                 (Gibco/BRL) used hosts propagation plasmids. addition,                                                                                 propagate R6K pir mutant derivatives, strains DH5a lpir (14) SM10 lpir
strate blocking activity (4–6, 19). Recently, chro-             (18) used. Plasmids pACYC184 (2), pBluescript SK(2) (Stratagene),
mosomally encoded aminoglycoside 29-N-acetyltransferase                     pBCKS (2) (Stratagene), pKNG101 (13) used cloning vectors. shown role O acetylation peptidogly-                   bacteria grown Luria-Bertani (LB) medium supplemented 15 g P. stuartii (19). enzyme, encoded aac(29)-Ia                 agar/liter needed. Antibiotics used following concentrations                                                                                 growth E. coli: ampicillin, 150 mg/ml; chloramphenicol, 25 mg/ml; streptomy-
gene, universal P. stuartii initially identified           cin, 25 mg/ml; tetracycline, 15 mg/ml; kanamycin, 20 mg/ml. growth P.
role aminoglycoside resistance (3, 20, 26). Presumably, ami-                 stuartii, antibiotics used following concentrations: ampicillin, 150
noglycosides true substrate AAC(29)-Ia                   mg/ml; chloramphenicol, 100 mg/ml; streptomycin 75, mg/ml; tetracycline, 30
acetylated structural similarity peptidoglycan.               mg/ml. Selection sucrose resistance P. stuartii 308C LB agar
                                                                                plates NaCl containing 5  sucrose.
   Regulation aac(29)-Ia expression complex. Recessive                       Isolation subcloning aarC. Sau3AI recombinant library P. stuartii
mutations loci, aarA, aarB, aarD, aarG,               chromosomal DNA pACYC184 described previously (14). Plasmid
increase aac(29)-Ia mRNA accumulation identified                      pACYC184.aarC contains approximately 1.7-kb Sau3A partial fragment (15, 20, 23). addition, transcriptional activator, aarP,               pACYC184. Digestion plasmid SalI released 2.0-kb fragment
                                                                                containing P. stuartii insert DNA 276 bp pACYC184 identified (14). additional level regulation includes                DNA BamHI cloning site SalI site. 2.0-kb SalI fragment repression mediated diffusible extracellular factor, AR-                   cloned SalI site pBluescript II SK(2), resulting pSK-2.0. Digestion
factor, acts unknown mechanism decrease                          pSK-2.0 BamHI released 600-bp fragment, subsequent religation aac(29)-Ia mRNA accumulation cells approach high density                     vector-containing fragment resulted pSK.aarC1.4, contained 1.4-
                                                                                kb insert entirely composed P. stuartii DNA. 1.4-kb insert cloned
(22).                                                                           pBCKS (2) 1.4-kb BamHI-SalI fragment, resulting pBC.aarC1.4.
   study reports identification characterization                Plasmid pBC.aarC1.4 subcloned digestion SspI BamHI, aarC gene P. stuartii. deduced AarC protein dis-                     released approximately 1.0-kb fragment subcloned played extensive identity GcpE Escherichia coli, gene                   EcoRV- BamHI-digested pBCKS (2) pBluescript II SK(2). 
                                                                                sulted pBC.aarC1.0 pSK.aarC1.0, respectively. isolate DNA frag-
product function unknown                         ment containing length version aarC gene, chromosomal DNA ported essential (1, 7). P. stuartii, role aarC             PR50 digested SalI fragments 4 6 kb ligated pBlue-
gene product regulation aac(29)-Ia specific cells                script II SK(2). Previously, Southern blot analysis demonstrated aarC                                                                                 approximately 5-kb SalI fragment. Colony hybridization 309-bp
                                                                                EcoRV fragment pBC.aarC1.4 used identify recombinant plasmids
                                                                                containing 5-kb SalI fragment length aarC gene. plasmid
                                                                                designated pSK.aarC5.0. Plasmid pPR25 contains approximately 0.7-kb
   * Corresponding author. Mailing address: Infectious Diseases Sec-            NruI fragment pSK.aarC5.0 cloned EcoRV site pBCKS (2).
tion 1110W, Wade Park Medical Center, 10701 E. Boulevard, Cleve-                Plasmid pPR26 contains 3.9-kb NruI-SalI fragment pSK.aarC5.0 cloned
land, OH 44106. Phone: (216) 791-3800, ext. 4674. Fax: (216) 229-8509.          EcoRV SalI sites pBCKS (2).
E-mail: pxr17@po.cwru.edu.                                                         isolate aarC1 mutation, chromosomal DNA PR60 digested

                                                                         2267
 2268       ET AL.                                                                                                                               J. BACTERIOL.


                                                            TABLE 1. Bacterial strains plasmids
  Strain plasmid                                              Genotype relevant markers                                                       Source

Strains
  E. coli
     XL1-Blue                  recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 Dlac-pro [F9 proAB lacIq lacZDM15 Tn10]                      Stratagene
     DH5a                      recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 DlacZYA-argF U169 f80dlacZDM15                               Gibco/BRL
     DH5a lpir                 DH5a lysogenized lpir                                                                                Macinga et al. (14)
     SM10 lpir                 thi thr leu tonA lacY supE recA RP4-2-Tc::Mu Kmr lpir                                                     Miller Mekalanos (18)
  P. stuartii
     PR50                      Wild type                                                                                                 et al. (20)
     PR500                     PR50 containing pR401 pACYC184.aarG                                                                   study
     PR60                      PR50 aarC1                                                                                                study
Plasmids
  pACYC184                     Medium-copy-number vector; Cmr Tcr                                                                        Chang Cohen (2)
  pKNG101                      R6K-derived suicide plasmid containing Strr sacB                                                      Kaniga et al. (13)
  pBluescript SK(2)            High-copy-number vector; Apr                                                                              Stratagene
  pBCKS (2)                    High-copy-number vector; Cmr                                                                              Stratagene
  pR401                        aac(29)-lacZ transcriptional fusion                                                                       Orosz (21)
  pACYC184.aarC                pACYC184 containing 1.7-kb P. stuartii chromosomal fragment                                               study
  pSK-2.0                      pBluescript SK(2)::2.0-kb SalI fragment pACYC184.aarC                                                study
  pSK.aarC1.4                  pBluescript SK(2)::1.4-kb SalI-BamHI fragment pSK-2.0                                                study
  pBC.aarC1.4                  pBCKS (2)::1.4-kb SalI-BamHI fragment pSK-2.0                                                        study
  pSK.aarC1.0                  pBluescript SK(2)::1.0-kb SspI-BamHI fragment pSK.aarC1.4                                            study
  pBC.aarC1.0                  pBCKS (2)::1.0-kb SspI-BamHI fragment pSK.aarC1.4                                                    study
  pBC.aarC::lacZ               pBC.aarC1.0::lacZ inserted unique NruI site                                                            study
  pKNG101.aarC::lacZ           pKNG101::4.5-kb SalI-BamHI fragment pBC.aarC::lacZ                                                   study
  pSK.aarC5.0                  pBluescript SK(2)::5.0-kb SalI chromosomal fragment PR50                                             study
  pPR25                        pBluescript SK(2)::0.7-kb NruI fragment pSK.aarC5.0                                                  study
  pPR26                        pBluescript SK(2)::3.9-kb NruI-SalI fragment pSK.aarC5.0                                             study
  pSK.aarC1.4mut               pBluescript SK(2)::1.4-kb SalI-BamHI fragment containing aarC1 allele                                     study
  pSK.aarC1.0mut               pSK.aarC1.0 substituted 320-bp NruI-BclI fragment pSK.aarC1.4mut                                study



 BamHI SalI, fragments range 1 2 kb ligated         cloned EcoRV site pBluescript II SK(2) used
pBluescript II SK(2) digested BamHI SalI. Colony hybridization           sequencing template. DNA sequence analysis insert described used identify plasmids 1.4-kb fragment            pBC.aarC1.4 indicated presence partial open reading frame 738 bp
containing mutant aarC gene. plasmid designated pSK.aarCmut.1.4.        capable encoding protein 246 amino acids truncated carboxy
   Construction aarC::lacZ disruption. Plasmid pBC.aarC1.0 containing        terminus. sequence remainder aarC coding region, cloned 1.0-kb portion aarC coding region linearized digestion NruI,      0.5-kb fragment pACYC184.aarC containing additional 39 coding region. cuts position 454 aarC coding region. promoterless lacZ        resulted additional 266 nucleotides downstream previous se-
cassette obtained pQF50 (8) digestion SmaI ScaI             quence;  stop codon open reading frame ligated correct orientation pBC.aarC, creating aarC::lacZ transcrip-    reached. complete sequence, plasmid pSK.aarC5.0, containing entire
tional fusion. DNA fragment containing fusion excised digestion        aarC gene 5.0-kb SalI fragment, isolated. Custom primers BamHI SalI cloned suicide vector pKNG101 (13), creating        used finish DNA sequence analysis. Protein homology searches pKNG101.aarC::lacZ. plasmid contains pir-dependent origin replica-         performed using blastp program National Center Biotechnology
tion, counterselectable sacB gene, streptomycin resistance gene.          Information.
introduce pKNG101.aarC::lacZ P. stuartii chromosome, E. coli SM10              b-Galactosidase assays. Plasmid pR401 containing aac(29)-lacZ transcrip-
lpir (18) containing pKNG101.aarC::lacZ mated P. stuartii strains          tional fusion described previously (21). b-Galactosidase activity described previously (21). Mating mixtures plated LB plates         reported Miller units (17). Reported values represent averages triplicate
taining streptomycin (75 mg/ml), tetracycline (30 mg/ml), X-Gal (5-bromo-        samples independent experiments.
4-chloro-3-indolyl-b-D-galactopyranoside). case P. stuartii strains       Nucleotide sequence accession number. sequence aarC sub-
taining plasmid DNA, ampicillin added concentration 300 mg/ml.      mitted GenBank assigned accession number U67933.
Selection loss integrated pKNG101.aarC::lacZ achieved growth 308C LB plates NaCl containing 5  sucrose. Southern blot
analysis performed strains digestion chromosomal DNA SalI                                            RESULTS
followed transfer nylon membrane. aarC probe contained 1.4-kb
BamHI-SalI fragment. probe specific lacZ 3.2-kb PstI fragment pMC1871 (Pharmacia).
                                                                                        Isolation aarC1 allele. chromosomal 29-N-acetyl-
   Northern blot analysis. RNA prepared Northern blot analysis using      transferase [AAC(29)-Ia] role O acetylation TRIzol reagent (Gibco/BRL) fractionated 1.2  agarose gel            peptidoglycan P. stuartii (19) acetylates ami-
containing 2.2 M formaldehyde transferred nylon membrane capillary       noglycosides (3, 20, 26). result, P. stuartii cells 
transfer. ensure equal loading transfer RNA nylon mem-
brane, RNAs directly photographed nylon filter UV illumination.
                                                                                     creased aac(29)-Ia expression resistant higher levels
Filters probed digoxigenin-labeled 602-bp TaqI-SspI fragment        aminoglycosides (14, 15, 20, 21). identify genes involved
containing aac(29)-Ia coding sequence. Filters developed Lumi-         regulating aac(29)-Ia expression, strategy gener-
Phos 530 (Boehringer Mannheim) exposed X-ray film.                            ate mutations simultaneously increased expression    DNA sequencing. Fluorescein-labeled universal reverse primers used sequence double-stranded DNA using AutoRead sequencing kit (Phar-
                                                                                     chromosomal copy aac(29)-Ia aac(29)-lacZ fusion
macia). Internal primers used needed gaps contiguous          present plasmid pR401 (21). addition, wanted sequence. Label incorporated sequencing reactions using flu-       prevent reisolation aarG mutations alter reg-
orescein-labeled dATP. sequencing reactions analyzed L.F.           ulation aac(29)-Ia (23).  used strain PR500,
automated sequencer (Pharmacia). entire nucleotide sequence strands aarC gene flanking DNA determined manner.
                                                                                     PR50 derivative containing pR401 [aac(29)-lacZ]
Specific templates sequencing generated follows. Digestion            pACYC184.aarG, compatible pACYC184 derivative
pBC.aarC1.4 EcoRV released fragments 335, 420, 267, 309, 80 bp,          containing aarG gene. PR500 forms white colonies  VOL. 179, 1997                                                        DENSITY-DEPENDENT REGULATOR aac(29)-Ia                           2269


plates containing X-Gal aminoglycoside resistance 4
mg gentamicin/ml. Selection mutants achieved plating approximately 108 cells PR500 LB plates contain-
ing 15 mg gentamicin/ml, X-Gal  select identify reg-
ulatory mutants), ampicillin (150 mg/ml; maintain pR401), chloramphenicol (100 mg/ml; maintain pACYC184.aarG). observed previously, colonies arose frequency 1026 1027 (20). Colonies grew conditions exhibited blue color analyzed  colonies
presumably resulted mutations trans-acting regulator aac(29)-Ia expression chromosomal copy aac(29)-Ia plasmid-encoded aac(29)-lacZ fusion increased. class mutants formed small blue
colonies identified, representative isolate, PR60/
pR401/pACYC184.aarG, characterized. strain cured pACYC184.aarG, resulting PR60/pR401, displayed phenotype identical PR500, indicating presence aarG, multicopy did alter effects aarC1 mutation. Introduction previously cloned
aarA, aarB, aarD genes (15, 20, 21) PR60/pR401 did result complementation (data shown), indicating PR60 contained new regulatory mutation, designated aarC1.
   aarC1 increases aac(2*)-Ia high cell density. accumu-
lation b-galactosidase wild-type PR50/pR401 PR60             FIG. 1. aarC density-dependent regulator. Total RNA (20 mg) pre-
aarC1/pR401 measured cells mid-log phase,          pared PR50 (wild-type) PR60 (aarC1) cells early log phase
8.9-fold increase b-galactosidase accumulation observed      (OD600 5 0.2) early stationary phase (OD600 5 1.2). experiment,
                                                                    lane 1 represents RNA PR50 lane 2 represents RNA PR60 aarC1. PR60 (32.1 6 2.4 Miller units) relative PR50 (3.6 6 0.2         RNA probed 602-bp TaqI-SspI fragment specific aac(29)-Ia.
Miller units). experiment repeated times           (B) RNA probed digoxigenin-labeled 0.4-kb PCR-generated fragment
gave increases 8.8- 9.2-fold, respectively, PR60.         specific aarP.
Northern blot analysis used directly examine effects aarC1 allele aac(29)-Ia mRNA accumulation.
RNA prepared wild-type PR50 PR60
(aarC1) cured plasmid pR401 log phase (optical density     introduced electroporation PR60/pR401 [aac(29)-
600 nm [OD600] 5 0.2) examined Northern blot anal-           lacZ] colonies normal growth phenotype iso-
ysis. Unexpectedly, levels aac(29)-Ia mRNA accumula-         lated. resulted isolation plasmids different
tion PR60 (aarC1) significantly different wild     inserts, containing common region DNA based type instances appeared decrease. Based      restriction mapping. Retransformation representative
result, effects aarC1 allele aac(29)-Ia expression    plasmid, pACYC184.aarC, demonstrated insert P. stu- examined various stages growth. RNA prepared         artii DNA responsible correcting slow growth phe- cells log phase (OD600 5 0.2) stationary phase          notype. addition, resulting transformants formed
(OD600 5 1.2), aac(29)-Ia mRNA accumulation ex-             white colonies X-Gal plates. slow growth
amined Northern blot analysis (Fig. 1A). levels           phenotype increased aac(29)-Ia expression corrected
aac(29)-Ia mRNA cells PR50 (wild type) PR60               wild type introduction plasmids, reason-
(aarC1) approximately equal log phase (Fig. 1).         able recombinant plasmids contained wild-type  late log/early stationary phase, PR60 demonstrated       aarC gene.
considerable increase accumulation aac(29)-Ia mRNA           sequence aarC coding region determined relative wild-type PR50.                                         described Materials Methods. deduced AarC pro-
   Increased expression transcriptional activator aarP    tein contained 365 amino acids exhibited 88  identity aarC1 background. Previously, identified tran-          stretch 362 amino acids GcpE protein E. coli
scriptional activator, AarP, activates aac(29)-Ia gene    (1) (Fig. 2). function GcpE unknown;  (14). increased aac(29)-Ia expression observed      proposed essential (1). Introduction E. coli aarC1 background resulted increased aarP          gcpE gene plasmid pSE401 (7) PR60 aarC1 restored
expression. accumulation aarP mRNA examined           wild-type growth levels, indicating gcpE functionally
Northern blot analysis shown Fig. 1B. low cell density,    substitute aarC. deduced AarC protein displayed aarC1 allele did significantly affect accumulation   86  homology 361 amino acids open reading frame
aarP mRNA PR60 relative wild-type PR50.            identified Haemophilus influenzae genome (accession
cells high density, accumulation aarP mRNA            number H64063) (9) 51  identity 333 amino acids significantly increased aarC1 background.                    YqfY Bacillus subtilis (accession number D84432).
   Cloning analysis aarC. PR60 aarC1 formed colonies            Identification aarC1 allele. Plasmid pSK.5.0 contain- considerably smaller wild-type PR50 24 h       ing entire aarC gene flanking DNA 5.0-kb SalI growth. aarC1 mutation selected spontane-          fragment capable complementing aarC1 mutation.
ously, reasoned single mutation responsible        Subclones fragment generated pBluescript SK slow growth phenotype increased aac(29)-       (2) contained approximately 700-bp NruI fragment
Ia expression.  isolate wild-type aarC gene,     (pPR25) 3.9-kb NruI-SalI fragment (pPR26) (Fig. 3).
recombinant library P. stuartii DNA pACYC184 (2, 14)          plasmid capable complementing aarC1 mu-
 2270       ET AL.                                                                                                                              J. BACTERIOL.




    FIG. 2. Comparison AarC GcpE. deduced amino acid sequences AarC GcpE aligned. Vertical lines indicate identical amino acids,
colons indicate conserved amino acids, dots indicate amino acids low similarity. position valine glycine substitution AarC mutant protein indicated position 136.



tation introduced PR60;  PR60 cells                             aarC::lacZ, integrated chromosome taining pPR26 unstable colonies rapidly                          PR50 conjugal mating described Materials Meth-
papillated fast-growing sectors. contrast, cells contain-                     ods. integration resulted streptomycin-resistant (Smr)
ing pPR25 remained small. fast-growing cells result                         sucrose-sensitive (Sucs) colonies blue correction aarC1 allele high frequency                           presence X-Gal. Integration pKNG101.aarC::lacZ combination pPR26 chromosome. case,                           occur crossovers (Fig. 4) result aarC1 mutation predicted downstream NruI site.                        strain diploid aarC. Crossover 1 yield functional
Furthermore, plasmid pSK.aarC1.0 containing 1.0-kb SspI-                            copy aarC;  crossover 2 result non-
BamHI fragment shown partially complement aarC1
allele. results indicated aarC1 mutation likely reside NruI BamHI interval.
   chromosomal DNA fragment containing aarC1 allele cloned PR60 1.4-kb SalI-BamHI fragment pBluescript SK(2), resulting plasmid pSK.aarC1.4mut. plasmid failed complement aarC1 allele intro-
duced PR60. presence pSK.aarC1.4mut eith-
er wild-type P. stuartii PR50 E. coli XL1 substantially
reduced growth rate cells, indicating mutant
AarC gene product dominant-negative effect. localize aarC1 mutation 1.4-kb fragment,
restriction fragment exchanges performed pSK.aarC1.0 pSK.aarC1.4mut. Substitution wild-
type 320-bp NruI-BclI fragment pSK.aarC1.0 mu-
tant fragment pSK.aarC1.4mut resulted E. coli trans-
formants slow growing, resulting hybrid
plasmid, pSK.aarC1.0mut, failed complement PR60. indicated aarC1 mutation 320-bp NruI-
BclI interval. nucleotide sequence fragment 
vealed single T G transversion resulting valine glycine substitution position 136, position conserved E. coli H. influenzae homologs (Fig. 2).
   aarC essential gene. previous report indicated                           FIG. 3. Mapping aarC1 allele. Recombinant plasmids containing gcpE essential gene E. coli (1). assess role                      aarC region shown. shaded area represents portion aarC gene
aarC P. stuartii, inserted promoterless lacZ cassette                    plasmid. ability plasmid complement marker rescue
                                                                                      aarC1 mutation shown. 1 (marker rescue), extensive formation papillae unique NruI site approximately aarC gene.                        colonies; 11 (complementation), restoration wild-type growth rate aarC::lacZ insertion transferred sacB                           aarC1 mutant; 1 (complementation), partial complementation; 2, comple-
taining suicide plasmid pKNG101 (13), resulting pKNG101.                           mentation.
 VOL. 179, 1997                                                        DENSITY-DEPENDENT REGULATOR aac(29)-Ia                                   2271




                                                                       FIG. 4. Southern blot analysis aarC::lacZ disruption.   structure
                                                                    plasmid pKNG101.aarC::lacZ depicted  5.0-kb SalI
                                                                    chromosomal region PR50 containing aarC shown immediately 
                                                                    Integration pKNG101.aarC::lacZ chromosome occur                                                                     552-bp interval 59 inserted lacZ cassette depicted crossover 1  1)
                                                                    579-bp interval 39 inserted lacZ cassette depicted                                                                     crossover 2  2). predicted structure chromosomal region                                                                     strain containing aarC::lacZ disruption shown 3. probe used                                                                     Southern blot analysis 1.4-kb SalI-BamHI fragment depicted                                                                     PR50 chromosomal region. (B C) Southern blot verification                                                                     aarC::lacZ disruption. DNAs digested SalI. Panel B represents
                                                                    DNA probed aarC. Lane 1, purified pSE401 plasmid DNA; lane 2, PR50/
                                                                    pSE401; lanes 3 7, putative PR50 aarC::lacZ/pSE401 mutants. Panel C rep-
                                                                    resents DNA probed lacZ gene. DNAs SalI digested. Lane 1,
                                                                    PR50/pSE401; lanes 2 6, putative PR50 aarC::lacZ/pSE401 mutants.




functional copies aarC, truncation        6). hybridization detected DNA PR50/
taining lacZ disruption. Southern blot analysis 28 Smr       pSE401 (Fig. 4C, lane 1).
Sucs blue colonies demonstrated contained pKNG101.            determine viability strain aarC::lacZ
aarC::lacZ integrated crossover 1 (data shown)      disruption dependent presence pSE401, retained functional copy aarC. unexpected,         grew PR50 (aarC::lacZ)/pSE401 absence ampicillin homology crossover 2 (579 bp versus 552 bp        approximately 12 generations plated single crossover 1). Excision integrated plasmid selection   colonies LB plates. resulting colonies (474 474 tested) 5  sucrose failed yield blue colonies corresponding        remained ampicillin resistant, indicating retained pSE401. aarC::lacZ disruption. results obtained       contrast, strain PR50/pKNG101.aarC::lacZ/pSE401, independent experiments, suggesting colonies containing        diploid aarC (Fig. 4), cured pSE401 frequencies aarC::lacZ disruption viable.                          50  conditions.  presence    test possibility, attempted resolve    gcpE pSE401 essential construction integrated copy pKNG101.aarC-lacZ PR50 transformed            aarC::lacZ disruption chromosome, resulting plasmid pSE401 containing E. coli gcpE gene (7).       strain requires pSE401 viability.
gcpE gene chosen previously shown complement growth defect PR60 aarC1, use                                          DISCUSSION gene limit potential problem recombina-
tional rescue aarC::lacZ disruption. Selection su-          aarC gene identified negative regulator crose resistance strain resulted approximately       aac(29)-Ia P. stuartii. missense allele (aarC1) resulted equal numbers blue white colonies. Southern blot anal-       increased accumulation aac(29)-Ia mRNA cells
ysis randomly chosen blue colonies confirmed pres-      high density. aarC1 allele increased ac-
ence aarC::lacZ disruption, demonstrated Fig. 4B       cumulation mRNA specific aarP, gene encoding C. probe specific aarC used, SalI fragment      transcriptional activator aac(29)-Ia (14). increase 5 kb corresponds aarC locus present           aarP expression specific cells high density (Fig.
PR50/pSE401 (Fig. 4B, lane 2). addition, cross-hybridiza-        1). possible model consistent observations tion seen fragment pSE401 (Fig. 4B, lanes 1       aac(29)-Ia overexpression aarC1 background simply
7). putative aarC::lacZ mutants 5.0-kb SalI         overexpression aarP. test possibility, fragment longer present replaced fragment       attempted introduce aarP::Cm disruption aarC1 approximately 8.5 kb size (lanes 3 7).         background;  attempts construct double mu-
expected size, lacZ cassette inserted aarC approx-   tant failed repeatedly.
imately 3.5 kb. confirm  probe specific lacZ          aarC1 allele recessive wild type, suggesting used putative aarC::lacZ mutants demonstrated          regulatory consequences aarC1 result loss hybridization 8.5-kb fragment (Fig. 4C, lanes 2         AarC function. Interestingly, presence aarC1 allele
 2272     ET AL.                                                                                                                 J. BACTERIOL.

 high-copy-number plasmid detrimental growth          probably essential function early cell growth. P. stuartii E. coli. interpretation result   essential nature aarC remarkable conservation AarC functions multimer overexpression       gene product different gram-negative mutant subunit interferes function wild-type         gram-positive bacteria make attractive target 
subunits. Alternatively, AarC interact complex         velopment new antimicrobials. proteins. Analysis AarC protein did reveal obvious functional motifs,  mechanism                                     ACKNOWLEDGMENTS regulates mRNA accumulation remains deter-              grateful J. Parker plasmid pSE401 comments mined. addition, hydropathy analysis AarC did reveal       manuscript. addition, thank D. Macinga review obvious signal sequence hydrophobic regions, suggest-         manuscript.
ing AarC cytoplasmic. AarC shared striking homology            work supported grant MCB9405882 National GcpE E. coli (1) H. influenzae (9) YqfY         Science Foundation Merit Review Award Depart-
product B. subtilis. high degree conservation      ment Veterans Affairs. proteins suggests involved important
                                                                                                        REFERENCES
housekeeping function. Attempts disrupt gcpE E. coli
                                                                      1. Baker, J., D. B. Franklin, J. Parker. 1992. Sequence characteriza- possible cells contained episomal copy           tion gcpE gene E. coli. FEMS Microbiol. Lett. 92:175–180.
gcpE, indicating gcpE essential (1). study dem-      2. Chang,  C. Y., S. N. Cohen. 1978. Construction characterization onstrated aarC required viability P.             amplifiable DNA cloning vehicles derived p15A cryptic miniplas-
stuartii. addition, AarC GcpE functionally equiva-            mid. J. Bacteriol. 134:1141–1156.
                                                                      3. Chevereau, M., P. Daniels, J. Davies, F. LeGoffic. 1974. Aminoglycoside
lent, introduction pSE401 containing E. coli gcpE              resistance bacteria mediated gentamicin acetyltransferase II, 
gene PR60 resulted complementation aarC1                  zyme modifying 29-amino group aminoglycoside antibiotics. Biochem-
allele allowed construction chromosomal                istry 13:598–603.
aarC::lacZ disruption. presence gene E. coli       4. Clarke,  J. 1993. Extent peptidoglycan O acetylation tribe Pro-
                                                                         teeae. J. Bacteriol. 175:4550–4553.
H. influenzae, contains aac(29)-Ia, suggests         5. Dupont, C.,  J. Clarke. 1991. Evidence N3O acetyl migration additional functions carried AarC. Consistent            mechanism O acetylation peptidoglycan Proteus mirabilis. J.  aarC1 allele resulted slow growth phe-          Bacteriol. 173:4318–4324.
notype altered cell morphology formation         6. Dupont, C.,  J. Clarke. 1991. Dependence lysozyme catalysed
                                                                         solubilization Proteus mirabilis peptidoglycan extent O-acetyla-
short rods, spherical.                                tion. Eur. J. Biochem. 195:763–769.
   aarC gene added list genes,         7. Eisenbeis, S. J., J. Parker. 1981. Strains Escherichia coli containing
includes aarA, aarB, aarD, aarG, serve negative              structural gene histidyl-tRNA synthetase high copy plasmid.
regulators aac(29)-Ia (15, 20, 21, 23). genes             Mol. Gen. Genet. 183:115–122.
                                                                      8. Farinha, M.,  Kropinski. 1990. Construction broad-host-range aarG locus, encodes putative response regu-             plasmid vectors easy visible selection analysis promoters. J. Bac-
lator sensor kinase, exhibits clear similarity transcrip-       teriol. 172:3496–3499.
tional regulators (23). aarA gene product appears        9. Fleishman, R. D., M. D. Adams, O. White, R.  Clayton, E. F. Kirkness,
integral membrane protein, aarD gene encodes CydD,                R. Kerlavage, C. J. Bult, J. F. Tomb, B.  Dougherty, J. M. Merrick, K.
                                                                         McKenney, G. Sutton, W. FithHugh, C.  Fields, J. D. Gocayne, J. D. Scott, component ABC transporter complex involved                R. Shirley, L.  Liu,  Glodeck, J. M. Kelley, J. F. Weidman, C.  Phillips,
formation functional cytochrome bd oxidase (15).                T. Spriggs, E. Hedblom, M. D. Cotton, T. R. Utterback, M. C. Hanna, D. T.
product aarB presently unknown. lack similarity             Nguyen, D. M. Saudeck, R. C. Brandon, L. D. Fine, J. L. Fritchman, J.  aar genes transcriptional regulators suggests             Furmann, N. S. Geoghagen, C. L. Gnehm, L.  McDonald, K. V. Small,
                                                                         C. M. Fraser, H. O. Smith, J. C. Venter. 1995. genome random act indirectly affect common cellular process          sequencing assembly Haemophilus influenzae Rd. Science 269:496– aac(29)-Ia aarP regulation coupled. obvious           512.
candidate process given identification aarD          10. Fuqua, W. C., S. C. Winans, E. Peter Greenberg. 1994. Quorum sensing
(cydD) electron transport.  purely specula-           bacteria: LuxR-LuxI family cell density-responsive transcriptional
                                                                         regulators. J. Bacteriol. 176:269–275.
tive time.                                                   11. Hawkey, P. 1984. Providencia stuartii: review multiply antibiotic resis-
   shown accumulation aac(29)-Ia mRNA                tant organism. J. Antimicrob. Chemother. 13:209–226. decreased high cell density accumulation      12. Kaiser, D., R. Losick. 1993. bacteria talk 
extracellular signaling molecule termed AR-factor (22).             Cell 73:873–885.
                                                                     13. Kaniga, K.,  Delor, G. Cornelis. 1991. wide-host-range suicide vector
type regulation termed quorum sensing mediated              improving reverse genetics gram-negative bacteria: inactivation accumulation diverse chemical signals, including               blaA gene Yersinia enterocolitica. Gene 109:137–141.
amino acids, peptides, acyl derivatives homoserine lac-       14. Macinga, D. R., M. M. Parojcic, P. N.  1995. Identification tone (10, 12, 24). requirement high cell density              analysis aarP, transcriptional activator 29-N-acetyltransferase                                                                          Providencia stuartii. J. Bacteriol. 177:3407–3413.
observe aarC mutant phenotype raises possibility        15. Macinga, D. R., P. N.  1996. aarD, Providencia stuartii homolog
AarC involved extracellular signaling process.          cydD: role 29-N-acetyltransferase expression, cell morphology possibilities exist including requirement aarC AR-              growth presence extracellular factor. Mol. Microbiol. 19:511–
factor production ability respond AR-factor,         520.
                                                                     16. McHale, P., F. Walker, B. Scully, L. English, C. T. Keane. 1981. Provi-
experiments progress examine possibilities. Al-          dencia stuartii infections: review 117 cases year period. J.
ternatively, aarC regulate gene expression response            Hosp. Infect. 2:155–165. density-dependent signals oxygen nutrient       17. Miller, J. H. 1972. Experiments molecular genetics. Cold Spring Harbor
depletion growth rate. physiological significance         Laboratory, Cold Spring Harbor, N.Y.
                                                                     18. Miller, V. H., J. J. Mekalanos. 1988. novel suicide vector use
regulation related role aac(29)-Ia O                construction insertion mutations: osmoregulation outer membrane
acetylation peptidoglycan, modification affects deg-          proteins virulence determinants Vibrio cholerae requires toxR. J.
radation muramidases control autolytic activ-            Bacteriol. 170:2575–2583.
ity (4–6, 19). decrease aac(29)-Ia high density        19. Payie, K. G., P. N. Rathe